Facebook
Instagram
Linkedin
Youtube
Start
News
Studio
Events
Newsletter
About BioStock
Contact us
Career
Search
BioStock
Start
News
Studio
Events
Newsletter
About BioStock
Contact us
Career
Home
Search
Iconovo
-
search results
If you're not happy with the results, please do another search
The future of obesity treatment: Iconovo develops intranasal semaglutide
16 September, 2024
BioStock Global Forum 2024
3 June, 2024
Full focus on financing and new CEO for Arcede
22 May, 2024
Iconovo initiates development of inhaled obesity treatment
21 May, 2024
New results confirmation for Arcede Pharma
10 May, 2024
Arcede aims for clinic with TO1
8 January, 2024
Busy days for Iconovo at BIO-Europe
20 November, 2023
Arcede proceeds to stability study in collaboration with Iconovo
20 November, 2023
Interviews from LSX Nordic Congress
11 October, 2023
Iconovo welcomes Gerald Engström as largest shareholder through share issue
9 October, 2023
Watch the interviews from BioStock Investor Meeting!
26 September, 2023
Watch the presentations from BioStock Investor Meeting!
22 September, 2023
Iconovo makes progress in the outlicensing process for ICOpre
18 September, 2023
Iconovo on the way to profitability
23 August, 2023
Iconovo initiates collaboration with Affilogic
22 June, 2023
Iconovo launch Accelerator Program
15 June, 2023
Iconovo initiates structured sales process for ICOpre
26 May, 2023
Arcede approaching dosing in tox study
17 May, 2023
Iconovo’s oxytocin treatment in clinical phase I study
15 May, 2023
Arcede Pharma and Iconovo receive funding from Swelife
4 April, 2023
BioStock Investor Meeting September 2023
22 March, 2023
Arcede Pharma looks ahead with strengthened team
15 February, 2023
Iconovo carries out directed share issue for continued value creation
14 February, 2023
Iconovo starts 2023 with negotiations for ICOpre
17 January, 2023
Several blockbuster patents to expire in 2023
16 December, 2022
The value of patent protection in life science
14 December, 2022
Arcede Pharma prepares for clinical studies
7 December, 2022
Iconovo establishes Nordic pharmaceutical sales
5 December, 2022
Iconovo reports Q3 and arranges pandemic event
8 November, 2022
Iconovo’s journey told by co-founder Orest Lastow
24 October, 2022
Arcede Pharma reports on the first quarter
27 September, 2022
Arcede Pharma’s CEO is ready for Spotlight
30 June, 2022
Watch day 2 of the BioStock Life Science Spring Summit
9 June, 2022
The BioStock Life Science Spring Summit starts now
8 June, 2022
Focus on company split for Respiratorius during Q4
17 May, 2022
BioStock Life Science Spring Summit, June 8-9, 2022
26 March, 2022
Strong start to 2022 for Respiratorius
18 February, 2022
Eight CEOs on their expectations at BIO-Europe
25 October, 2021
Respiratorius’ RCD405 shows efficacy in preclinical study
13 October, 2021
Iconovo looks to the US where it now meets quality requirements
24 September, 2021
Patent approved for Respiratorius’ COPD project
1 September, 2021
Iconovo’s partner explores opportunities in Bangladesh
27 August, 2021
Iconovo receives order for nasal Covid-19 vaccine development
16 July, 2021
Iconovo participates in vaccine race
8 July, 2021
The future of inhalation devices: making products more user-friendly
6 July, 2021
Biggest investment in Iconovo’s history
6 July, 2021
Iconovo’s new collaboration aims to optimise current inhalation products
6 July, 2021
Iconovo met innovation companies at BIO-Europe
6 July, 2021
Directed share issue of 60 million SEK to finance Iconovo’s new...
6 July, 2021
Spray inhalers – a major climate change culprit according to a...
6 July, 2021
Iconovo aims for more innovations in inhalation
6 July, 2021
New CEO gives Iconovo sharper focus
6 July, 2021
Video interview: Iconovo’s CEO presented the company at the LSX World...
6 July, 2021
Year-end report spotlights healthy progress for Iconovo
6 July, 2021
Iconovo’s CEO comments on the capital raise
6 July, 2021
High potential with Iconovo’s new inhalation platform ICOpre
5 July, 2021
Iconovo marginally impacted by Coronavirus pandemic
5 July, 2021
World TB Day: Iconovo’s ICOone platform in the spotlight
5 July, 2021
Iconovo boosts patent protection for ICOone
5 July, 2021
Analysts see high value in Iconovo’s business
5 July, 2021
1
2
Page 1 of 2
